Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group

BACKGROUND: Asthma medication ratio (AMR) ≥ 0.5 has been shown to predict asthma exacerbations. This study explores the impact of increasing or decreasing inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) use over a 7-year period on achieving an AMR of ≥ 0.5. OBJECTIVES: To (a) assess the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanford, Richard H., Nagar, Saurabh, Lin, Xiwu, O'Connor, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397934/
https://www.ncbi.nlm.nih.gov/pubmed/26521113
http://dx.doi.org/10.18553/jmcp.2015.21.11.1014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397934/
https://www.ncbi.nlm.nih.gov/pubmed/26521113
http://dx.doi.org/10.18553/jmcp.2015.21.11.1014

Ejemplares similares